Rapid Development of Optic Glioma in a Patient with Hybrid Phakomatosis: Neurofibromatosis Type 1 and Tuberous Sclerosis

References

1. ↵
   Deliganis AV, Geyer JR, Berger MS. Prognostic significance of type 1 neurofibromatosis (von Recklinghausen disease) in childhood optic glioma. Neurosurgery 1996;38:1114–1118

   CrossRefPubMedWeb of Science
2. ↵
   Pascual-Castroviejo I, Martinez Bermojo A, Lopez Marin V, et al. Optic gliomas in neurofibromatosis type 1. Neurologia 1994;9:173–177

   PubMed
3. ↵
   Lee TC, Sung ML, Chen JS. Tuberous sclerosis associated with neurofibromatosis: report of a case. J Formos Med Assoc 1994;93:797–801

   PubMed
4. Piccoli F, Demma MP, Pastore I, et al. A case of tuberous sclerosis associated with Recklinghausen’s disease: Attempted review of the problem of phacomatoses. Acta Neurol (Napoli) 1997;32:389–398
5. ↵
   Sanchez SL, Oliva AH, Castro TA, et al. Combination of tuberous sclerosis, neurofibromatosis and polycystic kidney. Rev Clin Exp 1968;108:311–318
6. ↵
   National Institute of Health Consensus Development Conference. Neurofibromatosis: conference statement. Arch Neurol 1988;45:575–578

   CrossRefPubMedWeb of Science
7. ↵
   Gomez MR. 00000000. In: Gomez ED, ed. Tuberous sclerosis. 2nd ed. New York: Raven Press;1985 :9–20
8. ↵
   Hulsebos TJ. Molecular genetic aspects of neurofibromatosis. Ned Tijdschr Geneeskd 1997;141:620–623

   PubMed
9. ↵
   Riva P, Corrado L, Natacci F, et al. NF1 microdeletion syndrome: refined FISH characterization of sporadic and familial deletions with locus specific probes. Am J Hum Genet 2000;66:100–109

   CrossRefPubMed
10. ↵
    Rasmussen SA, Overman J, Thomson SA et al. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1. Genes Chromosomes Cancer 2000;28:425–431

    CrossRefPubMed
11. ↵
    von Deimling A, Krone W, Menon AG. Neurofibromatosis type 1: pathology, clinical features and molecular genetics. Brain Pathol 1995;52:153–162
12. ↵
    Au KS, Hebert AA, Roach ES, Northrup H. Complete inactivation of the TSC2 gene leads to formation of hamartomas. Am J Hum Genet 1999;65:1790–1795

    CrossRefPubMedWeb of Science
13. ↵
    Ohno K. The results of recent research in neurocutaneous syndromes. Brain Dev 1998;30:109–114
14. ↵
    Lund AM, Skovby F. Optic gliomas in children with neurofibromatosis type 1. Eur J Pediatr 1991;150:853–858
15. ↵
    Mulvihill JJ. Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis): an update. Ann Intern Med 1990;113:39–52
16. ↵
    Elster AD. Radiologic screening in the neurocutaneous syndromes: strategies and controversies. AJNR Am J Neuroradiol 1992;13:1078–1082

    FREE Full Text
17. ↵
    Imes RK, Hoyt WF. Childhood chiasmal gliomas: update on the fate patients in the 1969 San Francisco study. Br J Opthalmol 1986;70:179–182

    Abstract/FREE Full Text
18. ↵
    Kanamori M, Shibuya M, Yoshida J, et al. Long-term follow-up of patients with optic glioma. Childs Nerv Syst 1985;1:272–278

    CrossRefPubMed
19. ↵
    Friedman JM, Birch P. An association between optic glioma and other tumors of the central nervous system in neurofibromatosis type 1. Neuropediatrics 1997;28:131–132

    PubMed
20. ↵
    Massry GG, Morgan CF, Chung SM. Evidence of optic pathway gliomas after previously negative neuroimaging. Ophthalmology 1997;104:930–935

    PubMedWeb of Science
21. ↵
    Gutmann D. H. Parallels between tuberous sclerosis complex and neurofibromatosis 1:common threads in the same tapestry. Semin Pediatr Neurol 1998;5:276–286

    CrossRefPubMed